BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 12080650)

  • 1. Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19.
    Zhang Z; Dai W; Zhu W; Rodriguez M; Lund H; Xia Y; Chen Y; Rau M; Schneider EA; Graham MB; Jobe S; Wang D; Cui W; Wen R; Whiteheart SW; Wood JP; Silverstein R; Berger JS; Kreuziger LB; Barrett TJ; Zheng Z
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102164. PubMed ID: 37680312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
    Xiong X; Zhao S; Wang Z; Lo L; Huang Q
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrinolytic system in chronic renal failure.
    Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
    Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
    Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
    Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of age, sex, body weight, smoking, blood lipids and fibrinolytic activities in healthy subjects].
    Xiong X; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):65-7. PubMed ID: 11938745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
    J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P; Berglund L
    Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
    Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of tissue plasminogen activator with a low plasminogen activator inhibitor-1 in a patient with postoperative bleeding.
    Stankiewicz AJ; Crowley JP; Steiner M
    Am J Hematol; 1991 Nov; 38(3):226-9. PubMed ID: 1951323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) in the regulation of fibrinolysis.
    Edelberg JM; Pizzo SV
    J Atheroscler Thromb; 1995; 2 Suppl 1():S5-7. PubMed ID: 9225222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
    Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.